Oragenics's total assets for Q4 2024 were $1.47M, a decrease of -71.70% from the previous quarter. OGEN total liabilities were $1.68M for the fiscal quarter, a -20.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.